Movement disorder. Specific developmental disorder of motor function
Conditions
Interventions
Intervention 1: Intervention group: In this group according to the protocol, patients receive balance exercises on the device for 20 minutes simultaneously with cerebellar tDCS stimulation. Interventi
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 40-60 years Patients who have symptoms of neuropathy such as tingling or numbness in the soles of the feet Patients who receive a Berg scale score of less than 45 Patients who are classified as moderate or severe according to the Toronto Clinical Scoring System
Exclusion criteria
Exclusion criteria: Other neurological diseases (multiple sclerosis, history of stroke, Parkinson's, myelopathy, cerebellar ataxia) The patient's use of chemotherapy drugs that induced neuropathy Mild neuropathy severity based on the Toronto Clinical Neuropathy Scale (score less than 8) Patients taking insulin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Barge Balance Scale(BBS). Timepoint: Before the intervention, after the intervention and one month after the intervention. Method of measurement: Balance test questionnaire (Berg).;Anterior-posterior stability indices. Timepoint: Before the intervention, after the intervention and one month after the intervention. Method of measurement: Biodex device (made in USA).;Overall stability index. Timepoint: Before the intervention, after the intervention and one month after the intervention. Method of measurement: Biodex device (made in USA).;Mediolateral stability index(internal - external). Timepoint: Before the intervention, after the intervention and one month after the intervention. Method of measurement: Biodex device (made in USA). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ehsani
Semnan University of Medical Sciences
Outcome results
None listed